SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Metropolis Healthcare

BSE: 542650 30 Sep 2025
Healthcare
₹ 2027.9
Metropolis Healthcare Limited specializes in Healthcare Service Provider within the Healthcare sector.

Metropolis Healthcare - Share Price & Details

Market Cap
₹10,437
High /Low
2,318 / 1,315
Stock P/E
68.6
Book Value
₹257.0
Dividend Yield
0.2
ROCE
14.7
ROE
₹11.5
Face Value
2.0
PEG Ratio
-5.9
EVEBITDA
₹31.7
Debt
204
CMP / FCF
53.0
Debt to equity
₹0.15
NP Ann
146
High price all time
3,580
Piotroski score
₹4.0
Graham Number
413.0
No. Eq. Shares
5.18
Net CF
₹-23.1
Net profit
153
Price to book value
7.84
Interest Coverage
₹11.5
Low price all time
905.0
Industry PE
38.6
Reserves
₹1,321
Free Cash Flow
₹196

Broker Recommendations

Date Author Type Reco Price Target Price Potential Source PDF Link
09 Aug 2025 ICICI Securities Buy ₹2,010.35 ₹2,400 13.1% moneycontrol View
02 Jul 2025 Emkay Global Financial Services Buy ₹1,725.35 ₹2,050 17.9% moneycontrol View
06 Feb 2025 ICICI Securities Buy ₹1,850.65 ₹2,250 22.1% moneycontrol View
05 Feb 2025 Emkay Global Financial Services Buy ₹1,803.9 ₹2,350 26.8% moneycontrol View
10 Dec 2024 Emkay Global Financial Services Buy ₹2,220.1 ₹2,400 7.9% moneycontrol View
11 Nov 2024 Emkay Global Financial Services Buy ₹2,155.1 ₹2,400 15.2% moneycontrol View

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
Metropolis Healthcare Limited3264.12355.823236.326.8410,43768.6
Jupiter Life Line Hospitals Li2908.23432.942779.426.6990351.4
HealthCare Global EnterprisesNANANANA9128246.0

Peer Comparison Chart


About Metropolis Healthcare

Metropolis Healthcare Limited, with Security Code 542650, is a leading player in the Healthcare Service Provider industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

Metropolis Healthcare acquires Ambika Pathology Laboratory

(22 Sep 2025)
Metropolis Healthcare Limited, India's second-largest and one of the most respected pathology chains, announced the acquisition of...
Read more →

Metropolis On Acquisition Drive

(22 Sep 2025)
Metropolis Healthcare Limited has announced its fourth acquisition in 10 months, including three regional players. The company has acquired...
Read more →

Truhealth Active (Female) + Body Vitals + Consult

(19 Sep 2025)
Tailored for proactive health monitoring, this gender-specific package includes tests across 9+ health categories, including Cancer Screening.
Read more →

Metropolis Healthcare acquires Kolhapur’s Ambika Pathology Laboratory

(19 Sep 2025)
image credit- shutterstock. Metropolis Healthcare has announced the completion of its fourth acquisition in the last 10 months,...
Read more →

Metropolis Healthcare shares soar 5% on acquiring Ambika Pathology; check details

(19 Sep 2025)
Metropolis Healthcare share price: The company plans to develop Ambika Pathology into a mini-regional reference lab, offering over 4000...
Read more →

METROPOLIS HEALTHCARE LTD (METROPOLIS.NS) Q1 24/25 earnings call transcript

(19 Sep 2025)
Metropolis Healthcare reported Q1 FY25 revenue of ₹313.4 crore, up 13.1% YoY, within the guided 13–15% range. EBITDA margin expanded 170 bps...
Read more →